These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1350060)

  • 1. Ethosuximide and tremor in Parkinson's disease: a pilot study.
    Pourcher E; Gomez-Mancilla B; Bédard PJ
    Mov Disord; 1992; 7(2):132-6. PubMed ID: 1350060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ethosuximide on rest tremor in the MPTP monkey model.
    Gomez-Mancilla B; Latulippe JF; Boucher R; Bédard PJ
    Mov Disord; 1992; 7(2):137-41. PubMed ID: 1350061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
    Hausner RS
    J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine as a diagnostic tool for a psychotic parkinsonian patient.
    Frye MA; Wirshing WC; Ames D
    J Clin Psychopharmacol; 1993 Oct; 13(5):359-60. PubMed ID: 7901246
    [No Abstract]   [Full Text] [Related]  

  • 5. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
    Metzer WS; Paige SR; Newton JE
    Mov Disord; 1993; 8(1):43-6. PubMed ID: 8093548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
    Arnold G; Trenkwalder C; Schwarz J; Oertel WH
    Mov Disord; 1994 Mar; 9(2):238-40. PubMed ID: 7910949
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
    Gomez-Mancilla B; Boucher R; Bédard PJ
    Mov Disord; 1992; 7(1):43-7. PubMed ID: 1348351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portable device for quantifying parkinsonian wrist rigidity.
    Caligiuri MP
    Mov Disord; 1994 Jan; 9(1):57-63. PubMed ID: 7908119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine withdrawal symptoms in a Parkinson's disease patient.
    Zesiewicz TA; Borra S; Hauser RA
    Mov Disord; 2002 Nov; 17(6):1365-7. PubMed ID: 12465085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
    Schindehütte J; Trenkwalder C
    Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia.
    Gurevich TY; Shabtai H; Korczyn AD; Simon ES; Giladi N
    Mov Disord; 2006 Oct; 21(10):1663-6. PubMed ID: 16941467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tremor and Parkinson's disease.
    Boddie H
    Practitioner; 1989 Aug; 233(1473):1101-2. PubMed ID: 2602338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease.
    Hellmann MA; Sabach T; Melamed E; Djaldetti R
    Biomed Pharmacother; 2008; 62(4):250-2. PubMed ID: 17967525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O; Kurtz G; Müller-Felber W; Modell S
    Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parkinson's disease and parkinsonian syndromes].
    Pollack P; Gaio JM; Perret J
    Rev Prat; 1989 Mar; 39(8):647-51. PubMed ID: 2727571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anomalies of asymmetry of clinical signs in parkinsonism.
    Toth C; Rajput M; Rajput AH
    Mov Disord; 2004 Feb; 19(2):151-7. PubMed ID: 14978669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
    Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG
    Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
    Rondot P; Bathien N
    Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
    [No Abstract]   [Full Text] [Related]  

  • 19. Does fluoxetine aggravate Parkinson's disease? A pilot prospective study.
    Montastruc JL; Fabre N; Blin O; Senard JM; Rascol O; Rascol A
    Mov Disord; 1995 May; 10(3):355-7. PubMed ID: 7651460
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of the early signs of drug induced parkinsonism.
    Arblaster LA; Lakie M; Mutch WJ; Semple M
    J Neurol Neurosurg Psychiatry; 1993 Mar; 56(3):301-3. PubMed ID: 8096240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.